Avid Bioservices announces expiration of HSR waiting period for acquisition

Avid Bioservices (CDMO) announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 with respect to the previously announced agreement for Avid to be acquired by GHO Capital Partners and Ampersand Capital Partners. The transaction remains on track to occur in the first quarter of 2025, subject to Avid stockholder approval and satisfaction of other customary closing conditions.